enow.com Web Search

  1. Ads

    related to: adpkd sensitivity criteria for prostate cancer

Search results

  1. Results from the WOW.Com Content Network
  2. Autosomal dominant polycystic kidney disease - Wikipedia

    en.wikipedia.org/wiki/Autosomal_dominant...

    Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common, life-threatening inherited human disorders and the most common hereditary kidney disease. [ 1 ] [ 2 ] It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes ...

  3. Polycystic kidney disease 3 (autosomal dominant) - Wikipedia

    en.wikipedia.org/wiki/Polycystic_kidney_disease...

    Polycystic kidney disease (ADPKD) is a life threatening hereditary disorder; it is characterized by the development of fluid-filled cyst formation and expansion of the kidney and other organs. [3] It is an autosomal dominant disease, and it is the most common hereditary disorders with a rate of occurrence of approximately 1 in 1000.

  4. PI-RADS - Wikipedia

    en.wikipedia.org/wiki/PI-RADS

    In a 2015 articles in the Journal of Urology, Thompson reported multi-parametric MRI detection of significant prostate cancer had sensitivity of 96%, specificity of 36%, negative predictive value and positive predictive values of 92% and 52%; when PI-RADS was incorporated into a multivariate analysis (PSA, digital rectal exam, prostate volume ...

  5. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is a major topic of ongoing research. From 2016–2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [122] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost. [123]

  6. PSMA scan - Wikipedia

    en.wikipedia.org/wiki/PSMA_scan

    However, the agent had poor sensitivity and saw little widespread use. [18] The first PET PSMA imaging agent, 68 Ga-PSMA-11, was approved by the FDA in 2020. [27] Listed indications include suspected metastasis prior to initial treatment, and recurrence of prostate cancer (based on elevated serum prostate-specific antigen (PSA) level). [28]

  7. Understanding ADPKD and Importance of Early Detection - AOL

    www.aol.com/news/understanding-adpkd-importance...

    Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic Kidney Disease (PKD) Awareness Day, an initiative that aims to ...

  1. Ads

    related to: adpkd sensitivity criteria for prostate cancer